WO2017013856A1 - Appareil d'aide au sauvetage - Google Patents

Appareil d'aide au sauvetage Download PDF

Info

Publication number
WO2017013856A1
WO2017013856A1 PCT/JP2016/003318 JP2016003318W WO2017013856A1 WO 2017013856 A1 WO2017013856 A1 WO 2017013856A1 JP 2016003318 W JP2016003318 W JP 2016003318W WO 2017013856 A1 WO2017013856 A1 WO 2017013856A1
Authority
WO
WIPO (PCT)
Prior art keywords
pulse
section
light
patient
lifesaving
Prior art date
Application number
PCT/JP2016/003318
Other languages
English (en)
Inventor
Tomoyoshi Natsui
Satoshi Hayashi
Tsutomu Wakabayashi
Taku Iwami
Toshihiro Hatakeyama
Tetsuro Nishimura
Takayuki Otani
Original Assignee
Nihon Kohden Corporation
Kyoto University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP2016096356A external-priority patent/JP6765622B2/ja
Application filed by Nihon Kohden Corporation, Kyoto University filed Critical Nihon Kohden Corporation
Priority to US15/745,342 priority Critical patent/US10966618B2/en
Priority to EP16745513.8A priority patent/EP3324839B1/fr
Priority to CN201680042202.XA priority patent/CN107847169B/zh
Publication of WO2017013856A1 publication Critical patent/WO2017013856A1/fr

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A61B5/024—Detecting, measuring or recording pulse rate or heart rate
    • A61B5/02416—Detecting, measuring or recording pulse rate or heart rate using photoplethysmograph signals, e.g. generated by infrared radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A61B5/024—Detecting, measuring or recording pulse rate or heart rate
    • A61B5/02416—Detecting, measuring or recording pulse rate or heart rate using photoplethysmograph signals, e.g. generated by infrared radiation
    • A61B5/02427—Details of sensor
    • A61B5/02433—Details of sensor for infrared radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/38—Applying electric currents by contact electrodes alternating or intermittent currents for producing shock effects
    • A61N1/39—Heart defibrillators
    • A61N1/3904—External heart defibrillators [EHD]

Definitions

  • the present disclosure relates to a lifesaving assisting apparatus for determining whether to perform an act of lifesaving.
  • the AED is an apparatus which delivers an electric shock to a patient in which fatal arrhythmia such as ventricular fibrillation or pulseless ventricular tachycardia has been detected, in order to revive the patient.
  • fatal arrhythmia such as ventricular fibrillation or pulseless ventricular tachycardia has been detected
  • electrode pads of the AED are pasted on the naked chest of the patient.
  • the AED analyzes an electrocardiogram acquired through the electrode pads to detect the fatal arrhythmia (for example, see Patent Literature 1).
  • unconscious patients include patients caused by encephalophy, low blood sugar, hemorrhagic shock, drowning, carbon monoxide poisoning, etc.
  • AED AED
  • it is unnecessary to use the AED on such a patient it is difficult for a general citizen to make an accurate judgment on this. Accordingly, in some cases, privacy of the patient may be unable to be sufficiently protected because the chest of the patient is made naked unnecessarily in front of the general public.
  • the necessity of a measure to make the chest naked also contributes to the hesitation of a lifesaver in using the AED.
  • a lifesaving assisting apparatus comprising: a light-emitting section configured to emit light to be irradiated on a body of a patient; a light-receiving section configured to output a signal corresponding to an intensity of light which has been transmitted through or reflected from the body of the patient; a pulse-amplitude Index acquiring section configured to analyze amplitude of the signal to acquire a pulse-amplitude Index of the patient; a pulse determining section configured to determine presence or absence of a pulse of the patient in accordance with the pulse-amplitude Index; and a notifying section configured to notify a result of determination made by the pulse determining section.
  • an objective parameter which is the pulse-amplitude Index of the patient is used. Accordingly, presence or absence of the pulse of the patient can be determined accurately no matter who handles the lifesaving assisting apparatus.
  • presence or absence of the pulse can be determined by the pulse determining section as long as a pulse wave signal corresponding to several cycles to about ten cycles can be acquired. Accordingly, presence or absence of the pulse of the patient can be determined rapidly no matter who handles the lifesaving assisting apparatus.
  • a lifesaver can be notified of an accurate determination result about presence or absence of the pulse of the patient. Accordingly, for example, the lifesaver can avoid unnecessarily undressing the patient when it is not necessary to use the AED. In this manner, it is possible to protect privacy of the patient. Thus, it is possible to provide the lifesaver with proper information about whether to perform an act of lifesaving in order to assist the lifesaver while taking the privacy of the patient into consideration.
  • Fig. 1 is a diagram showing the functional configuration of a lifesaving assisting apparatus according to one embodiment.
  • Fig. 2A is a diagram for explaining a definition of a pulse rate.
  • Fig. 2B is a diagram for explaining a definition of an inflection point number.
  • Fig. 2C is a diagram for explaining the definition of the inflection point number.
  • Fig. 2D is a diagram for explaining the definition of the inflection point number.
  • Fig. 3A is a flowchart showing process performed by the lifesaving assisting apparatus of Fig. 1.
  • Fig. 3B is a diagram showing a typical normalized pulse wave determined as presence of the pulse.
  • Fig. 3C is a diagram showing a typical normalized pulse wave determined as absence of the pulse.
  • Fig. 1 is a diagram showing the functional configuration of a lifesaving assisting apparatus according to one embodiment.
  • Fig. 2A is a diagram for explaining a definition of a pulse rate.
  • Fig. 2B is
  • FIG. 4A is a flowchart showing process performed by the lifesaving assisting apparatus of Fig. 1.
  • Fig. 4B is a flowchart showing process performed by the lifesaving assisting apparatus of Fig. 1.
  • Fig. 5 is a diagram showing one example of how to use the lifesaving assisting apparatus of Fig. 1.
  • Fig. 1 shows the functional configuration of a lifesaving assisting apparatus 1 according to one embodiment.
  • the lifesaving assisting apparatus 1 is an apparatus which detects presence or absence of a pulse of a patient 100 to thereby determine whether to perform an act of lifesaving.
  • the lifesaving assisting apparatus 1 is provided with a light-emitting section 21.
  • the light-emitting section 21 is configured to emit light to be irradiated on the body of the patient 100.
  • the body of the patient 100 means tissues where a blood flow exists.
  • a semiconductor light-emitting element which can emit light having a predetermined wavelength may be used as the light-emitting section 21.
  • the semiconductor light-emitting element include a light-emitting diode (LED), a laser diode, an organic EL element, etc. Infrared light IR and red light R may be used as examples of the light having the predetermined wavelength.
  • the lifesaving assisting apparatus 1 is provided with a light emission controlling section 31.
  • the light emission controlling section 31 is configured to control switching on/off of a light source in the light-emitting section 21.
  • the lifesaving assisting apparatus 1 is provided with a light-receiving section 22.
  • the light-receiving section 22 is configured to output a signal corresponding to intensity of the light transmitted through or reflected from the body of the patient 100.
  • an optical sensor having sensitivity to the wavelength of the light emitted from the light-emitting section 21 may be used as the light-receiving section 22.
  • the optical sensor include a photodiode, a phototransistor and a photoresistor.
  • the lifesaving assisting apparatus 1 is provided with a pulse-amplitude Index acquiring section 32.
  • the pulse-amplitude Index acquiring section 32 is configured to analyze amplitude of a signal outputted from the light-receiving section 22 to acquire a pulse-amplitude Index of the patient 100.
  • the pulse-amplitude Index will be described with reference to Fig. 2A.
  • the signal outputted from the light-receiving section 22 is a pulse wave.
  • the pulse-amplitude Index acquiring section 32 is provided with a filter which extracts a DC component from the pulse wave. That is, the pulse-amplitude Index acquiring section 32 is configured to obtain a pulsating component and a non-pulsating component from the pulse wave signal outputted from the light-receiving section 22.
  • the pulsating component during the change of the intensity of the light detected by the light-receiving section 22 is mainly an amount of contribution from arterial blood
  • the non-pulsating component is mainly an amount of contribution from the tissues or venous blood.
  • the pulse-amplitude Index acquiring section 32 is configured to acquire a normalized pulse wave PW in order to eliminate a component depending on the patent 100 personally.
  • the normalized pulse wave PW is obtained by dividing the pulsating component by the non-pulsating component.
  • Amplitude of the normalized pulse wave PW is defined as pulse-amplitude Index X.
  • the amplitude may change between a maximum value P1 and a next maximum value P2 which exist before and behind a minimum value B of a certain specific wave because the normalized pulse wave PW drifts.
  • the amplitude in the minimum value B takes a value between (P1-B) and (P2-B).
  • the pulse-amplitude Index X can be expressed by the following expression by way of example.
  • A1 designates a difference in amplitude (absolute value) between the maximum value P1 at a time point at which the amplitude of the normalized pulse wave PW takes the maximum value P1 and the minimum value B.
  • A2 designates a difference in amplitude (absolute value) between the maximum value P2 at a time point at which the amplitude of the normalized pulse wave PW takes the maximum value P2 and the minimum value B. That is, the pulse-amplitude Index X in the example is given as an average value of A1 and A2. However, the pulse-amplitude Index X may be set at any value between A1 and A2.
  • the pulse-amplitude Index acquiring section 32 acquires a pulse-amplitude Index X as to a next signal cycle defined by the maximum value P2 and a maximum value P3.
  • the pulse-amplitude Index acquiring section 32 is configured to acquire a representative pulse-amplitude Index based on a plurality of pulse-amplitude Indices X acquired thus within a predetermined period.
  • the representative pulse-amplitude Index is defined as an average value of the plurality of pulse-amplitude Indices X.
  • samples accounting for a predetermined percentage are removed from the plurality of pulse-amplitude Indices X acquired within the predetermined period and an average value of the remaining samples is obtained.
  • top 25% may be used as the predetermined percentage.
  • two samples are removed in descending order in the value of the pulse-amplitude Index X from the eight samples and a representative pulse-amplitude Index is obtained as an average value of the remaining six samples.
  • the lifesaving assisting apparatus 1 is provided with a pulse determining section 33.
  • the pulse determining section 33 is configured to determine presence or absence of the pulse of the patient 100 based on the pulse-amplitude Indices X acquired by the pulse-amplitude Index acquiring section 32. Specifically, the pulse determining section 33 is configured to determine presence or absence of the pulse of the patient 100 based on whether the representative pulse-amplitude Index acquired by the pulse-amplitude Index acquiring section 32 is lower than a predetermined threshold. For example, 1% may be used as the threshold.
  • the pulse determining section 33 is configured as follows. That is, in a case where the representative pulse-amplitude Index is lower than the threshold, the pulse determining section 33 determines that the patient 100 has no pulse. When the representative pulse-amplitude Index is no lower than the threshold, the pulse determining section 33 determines that the patient 100 has a pulse.
  • the lifesaving assisting apparatus 1 is provided with a notifying section 34.
  • the notifying section 34 is configured to notify a result of the determination made by the pulse determining section 33.
  • the notification is performed by at least one of optical notification (light emission of an LED, display of a message on a display device, etc.), acoustic notification (a guidance message, a melody, a beep, etc.), and vibratory notification.
  • Cardiogenic syncope belongs to a case in which an electric shock does not have to be delivered.
  • the cardiogenic syncope can be judged based on the fact that there is no pulse.
  • Syncope caused by encephalopathy, massive bleeding, low blood sugar, anemia, hypocapnia, etc. belongs to a case in which an electric shock does not have to (or must not) be delivered.
  • Such cardiogenic syncope can be judged based on the fact that there is a pulse.
  • an objective parameter which is the pulse-amplitude Index X of the patient 100 is used. Accordingly, presence or absence of the pulse of the patient 100 can be determined accurately no matter who handles the lifesaving assisting apparatus 1. In addition, presence or absence of the pulse can be determined by the pulse determining section 33 as long as a pulse wave signal corresponding to several cycles to about ten cycles can be acquired. Accordingly, presence or absence of the pulse of the patient 100 can be determined rapidly no matter who handles the lifesaving assisting apparatus 1.
  • the lifesaver can be notified of an accurate determination result about presence or absence of the pulse of the patient 100. Accordingly, for example, the lifesaver can avoid unnecessarily undressing the patient 100 when it is not necessary to use the AED. In this manner, it is possible to protect privacy of the patient 100. Thus, it is possible to provide the lifesaver with proper information about whether to perform an act of lifesaving in order to assist the lifesaver while taking the privacy of the patient into consideration.
  • the pulse-amplitude Index acquiring section 32 is configured to acquire the pulse-amplitude Index X based on the infrared light IR emitted from the light-emitting section 21.
  • a light source used in a probe of a pulse oximeter generally used in critical care can be used. It is unnecessary to prepare a separate light source. Therefore, it is possible to suppress the total cost for providing the lifesaving assisting apparatus 1.
  • the infrared light is hardly affected by the color of skin when it is transmitted through or reflected from the body of the patient 100. In this manner, accuracy of the acquired pulse-amplitude Index X is improved, and accuracy of determination of presence or absence of the pulse made by the pulse determining section 33 in the subsequent stage is also improved. Accordingly, it is possible to provide the lifesaver with more proper information about whether to perform an act of lifesaving in order to assist the lifesaver while taking the privacy of the patient into consideration.
  • the pulse determining section 33 may be configured to determine presence or absence of the pulse of the patient 100 based on not only the aforementioned pulse-amplitude Index X but also an inflection point number N within a predetermined time duration in the signal outputted from the light-receiving section 22. For example, one second may be used as the predetermined time duration.
  • the “inflection point number” herein is defined as the number of times in which a differential value of a normalized pulse wave PW alternates between positive and negative.
  • the differential value of the normalized pulse wave PW changes from positive to negative and changes to positive again. Accordingly, the inflection point number N is 2.
  • the differential value of the normalized pulse wave PW reaches zero in the middle but does not alternate between positive and negative before and behind the zero. Accordingly, the inflection point number N is 0.
  • Fig. 3A is a flowchart showing a determination process performed by the pulse determining section 33 in this embodiment.
  • the pulse determining section 33 determines whether the pulse-amplitude Index X (representative pulse-amplitude Index) of the patient 100 acquired by the pulse-amplitude Index acquiring section 32 is lower than a predetermined threshold (step S11).
  • the pulse determining section 33 When it is determined that the pulse-amplitude Index X is lower than the predetermined threshold (Y in the step S11), the pulse determining section 33 counts the inflection point number N of the normalized pulse wave PW in a predetermined period, and determines whether the inflection point number N is lower than a first threshold (step S12). For example, 10 may be used as the first threshold.
  • the pulse determining section 33 determines that the patient 100 has a pulse (step S13). This situation means that the result determined as absence of the pulse based on the pulse-amplitude Index X is reversed by the determination based on the inflection point number N.
  • the pulse determining section 33 determines that the patient 100 has no pulse (step S14). This situation means that the result determined as absence of the pulse based on the pulse-amplitude Index X is confirmed by the determination based on the inflection point number N.
  • the pulse determining section 33 When it is determined that the pulse-amplitude Index X is no lower than the predetermined threshold (N in the step S11), the pulse determining section 33 counts the inflection point number N of the normalized pulse wave PW within the predetermined period and determines whether the inflection point number N is lower than a second threshold (step S15). For example, 15 may be used as the second threshold.
  • the pulse determining section 33 determines that the patient 100 has a pulse (step S16). This situation means that the result determined as presence of the pulse based on the pulse-amplitude Index X is confirmed by the determination based on the inflection point number N.
  • the pulse determining section 33 determines that the patient 100 has no pulse (step S17). This situation means that the result determined as presence of the pulse based on the pulse-amplitude Index X is reversed by the determination based on the inflection point number N.
  • Fig. 3B shows a typical normalized pulse wave PW determined as presence of the pulse.
  • the inflection point number N in an illustrated period is lower than 10.
  • Fig. 3C shows a typical normalized pulse wave PW determined as absence of the pulse.
  • the inflection point number N in the illustrated period is higher than 100.
  • the inflection point number N is added to determination criteria. In this manner, accuracy of determination of presence or absence of the pulse is improved. Accordingly, it is possible to provide the lifesaver with more proper information about whether to perform an act of lifesaving in order to assist the lifesaver while taking the privacy of the patient into consideration.
  • the pulse determining section 33 is configured to acquire the inflection point number N based on the infrared light IR emitted from the light-emitting section 21.
  • the lifesaver According to such a configuration, it is possible to use a light source used in a probe of a pulse oximeter generally used in critical care. It is therefore unnecessary to prepare a separate light source. Accordingly, it is possible to suppress the total cost for providing the lifesaving assisting apparatus 1.
  • the infrared light is hardly affected by the color of skin when it is transmitted through or reflected from the body of the patient 100. In this manner, accuracy of the acquired inflection point number N is improved, and accuracy of determination of presence or absence of the pulse made by the pulse determining section 33 in the subsequent stage is also improved. Accordingly, it is possible to provide the lifesaver with more proper information about whether to perform an act of lifesaving in order to assist the lifesaver while taking the privacy of the patient into consideration.
  • the lifesaving assisting apparatus 1 may be provided with a pulse re-determining section 35.
  • the light-emitting section 21 is configured to emit infrared light IR and red light R.
  • the light-receiving section 22 is configured to output signals respectively corresponding to intensities of the infrared light IR and the red light R transmitted through or reflected from the body of the patient 100.
  • the pulse re-determining section 35 is configured as follows.
  • the pulse re-determining section 35 acquires arterial oxygen saturation (SpO2) and a heart rate of the patient 100 based on the signals outputted from the light-receiving section 22 and re-determines presence or absence of the pulse of the patient 100 based on these biological parameters.
  • SpO2 arterial oxygen saturation
  • a process for acquiring the arterial oxygen saturation and the heart rate from the intensities of the infrared light and the red light transmitted through or reflected from biological tissues is based on the principles of the pulse oximeter. Since the process per se is widely known, detailed description thereof will be omitted.
  • Fig. 4A is a flowchart illustrating operation of the pulse re-determining section 35 in the example.
  • a determination process is performed by the pulse determining section 33 (step S1).
  • a re-determination process is executed by the pulse re-determining section 35 (step S2).
  • Fig. 4B is a flowchart showing a specific flow of the re-determination process.
  • the pulse re-determining section 35 determines whether the acquired arterial oxygen saturation of the patient 100 is lower than a predetermined threshold (step S21). For example, 85% may be used as the threshold.
  • the pulse re-determining section 35 determines whether the acquired heart rate of the patient 100 is lower than a predetermined threshold (step S22). For example, 40 times per minute may be used as the threshold.
  • the pulse re-determining section 35 determines that the patient 100 has a pulse (step S23). This situation means that the result determined as presence of the pulse by the pulse determining section 33 is confirmed by the re-determination made by the pulse re-determining section 35.
  • the pulse re-determining section 35 determines that the patient 100 has no pulse (step S24). This situation means that the result determined as presence of the pulse by the pulse determining section 33 is reversed by the re-determination made by the pulse re-determining section 35.
  • the pulse re-determining section 35 provides a fail-safe function in the lifesaving assisting apparatus 1. In this manner, even when the patient 100 who should be essentially determined as having no pulse has been determined as having a pulse by the pulse determining section 33 for some reason, the patient 100 can be determined as having no pulse by the pulse re-determining section 35. Accordingly, it is possible to provide the lifesaver with more proper information about whether to perform an act of lifesaving in order to assist the lifesaver while taking the privacy of the patient into consideration.
  • step S21 the sequence of the determination about the arterial oxygen saturation (step S21) and the determination about the heart rate (step S22) may be reverse to each other.
  • configuration may be made so that only one of the determination about the arterial oxygen saturation (step S21) and the determination about the heart rate (step S22) is performed.
  • Fig. 5 schematically shows one example of how to use the lifesaving assisting apparatus 1.
  • the lifesaving assisting apparatus 1 is provided with a probe 2 and a casing 3.
  • the probe 2 includes the light-emitting section 21 and the light-receiving section 22.
  • the light emission controlling section 31, the pulse-amplitude Index acquiring section 32, the pulse determining section 33, the notifying section 34 and the pulse re-determining section 35 are received in the casing 3.
  • the probe 2 including the light-emitting section 21 and the light-receiving section 22 is configured to be able to be mounted on a forehead 101 of the patient 100.
  • the forehead 101 is a region which is hardly affected by body motion. It is therefore possible to improve accuracy of determination of presence or absence of the pulse. Accordingly, it is possible to provide the lifesaver with more proper information about whether to perform an act of lifesaving in order to assist the lifesaver while taking the privacy of the patient into consideration.
  • the light-emitting section 21 is configured to emit infrared light or red light
  • a probe of a pulse oximeter can be used. Since a separate probe does not have to be prepared, it is possible to suppress the total cost for providing the lifesaving assisting apparatus 1.
  • the lifesaving assisting apparatus 1 executes a notification process (step S3) when the determination process (step S1) results in a conclusion that the patient 100 has no pulse or when the re-determination process (step S2) results in a conclusion that the patient 100 has no pulse.
  • the notifying section 34 provides information for promoting the lifesaver to use the AED. For example, voice guidance “No pulse can be detected. Please use AED.” can be outputted.
  • the lifesaver mounts electrodes 201 of an AED 200 on a chest 102 of the patient 100 and executes a lifesaving measure in accordance with the voice guidance of the AED 200.
  • the lifesaver may be replaced by another lifesaver who can use the AED 200.
  • certainty of leading to use of the AED 200 can be improved.
  • the notifying section 34 provides information for promoting the lifesaver to perform sternum compressions. For example, voice guidance “No pulse can be detected. Please perform sternum compressions.” can be outputted. The lifesaver performs sternum compressions on the chest 102 of the patient 100.
  • the lifesaver may be replaced by another lifesaver who can perform a measure.
  • certainty of leading to lifesaving can be improved.
  • the pulse determining section 33 can continuously perform the determination process for determining presence or absence of the pulse.
  • the notifying section 34 may be configured to provide information for promoting the lifesaver to suspend performance of sternum compressions in a case where it is determined that the patient 100 has a pulse although it has been once determined as having no pulse. For example, voice guidance “Pulse has been restarted. Please do not perform sternum compressions.” can be outputted.
  • the lifesaving assisting apparatus 1 may perform the notification process (step S3) for sending notification of the fact that the patient 100 has a pulse. Then, the lifesaving assisting apparatus 1 re-execute the determination process (step S1) with the pulse determining section 33.
  • the pulse determining section 33 continuously performs the determination process for determining presence or absence of the pulse even after determining that the patient 100 has a pulse.
  • the aforementioned notification process is performed in a case where the determination process performed continuously results in a conclusion that the patient 100 has fallen into a no-pulse condition.
  • the functions of the light emission controlling section 31, the pulse-amplitude Index acquiring section 32, the pulse determining section 33, the notifying section 34 and the pulse re-determining section 35 are at least partially achieved by software executed by the cooperation of a processor and a memory which are connected to each other communicably.
  • a CPU or an MPU may be used as the processor by way of example.
  • An RAM or an ROM may be used as the memory by way of example.
  • the functions of the light emission controlling section 31, the pulse-amplitude Index acquiring section 32, the pulse determining section 33, the notifying section 34 and the pulse re-determining section 35 may be at least partially achieved by hardware such as an ASIC and an FPGA, or by a combination of hardware and software.
  • the infrared light IR is used for acquiring the pulse-amplitude Index X and the inflection point number N in the aforementioned embodiment.
  • both the infrared light IR and the red light R may be used for acquiring the pulse-amplitude Index X and the inflection point number N, or only the red light R may be used for acquiring the pulse-amplitude Index X and the inflection point number N.
  • Switching on/off of light sources for emitting the respective lights may be controlled suitably by the light emission controlling section 31.
  • a transmissive type pulse oximeter may be configured to be mounted on the tip of a finger, the tip of a toe, an ear, etc. Also in the case, it is possible to determine presence or absence of the pulse without undressing the patient 100.
  • the probe 2 does not have to be always a probe of a pulse oximeter.
  • the probe 2 may be configured as at least a part of an instrument (an ultrasonic blood flowmeter, an electromagnetic blood flowmeter, a laser blood flowmeter, a Doppler blood flowmeter, etc.) using any of an ultrasonic wave, an electromagnetic wave and laser light.
  • the probe 2 may be mounted on a neck portion, an arm portion or a leg portion of the patient 100. In any case, it is possible to determine presence or absence of the pulse while suppressing exposure of the skin of the patient 100 to the minimum.
  • the notifying section 34 may be configured to promote the lifesaver to use not just the AED 200 but any general defibrillator.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Medical Informatics (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Physiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)

Abstract

Une section d'émission de lumière (21) émet de la lumière devant être irradiée sur le corps d'un patient (100). Une section de réception de lumière (22) délivre en sortie un signal correspondant à une intensité de la lumière qui a été transmis à travers, ou réfléchie depuis, le corps du patient (100). Une section d'acquisition d'Indice d'amplitude de pouls (32) analyse l'amplitude du signal pour acquérir un Indice d'amplitude de pouls du patient (100). Une section de détermination de pouls (33) détermine la présence ou l'absence d'un pouls du patient (100) en fonction de l'Indice d'amplitude de pouls. Une section de notification (34) notifie un résultat de la détermination effectuée par la section de détermination de pouls (33).
PCT/JP2016/003318 2015-07-17 2016-07-13 Appareil d'aide au sauvetage WO2017013856A1 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US15/745,342 US10966618B2 (en) 2015-07-17 2016-07-13 Lifesaving assisting apparatus
EP16745513.8A EP3324839B1 (fr) 2015-07-17 2016-07-13 Appareil d'aide au sauvetage
CN201680042202.XA CN107847169B (zh) 2015-07-17 2016-07-13 救生辅助设备

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2015143008 2015-07-17
JP2015-143008 2015-07-17
JP2016096356A JP6765622B2 (ja) 2015-07-17 2016-05-12 救命支援装置
JP2016-096356 2016-05-12

Publications (1)

Publication Number Publication Date
WO2017013856A1 true WO2017013856A1 (fr) 2017-01-26

Family

ID=56557865

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2016/003318 WO2017013856A1 (fr) 2015-07-17 2016-07-13 Appareil d'aide au sauvetage

Country Status (1)

Country Link
WO (1) WO2017013856A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112469333A (zh) * 2018-07-26 2021-03-09 皇家飞利浦有限公司 用于检测对象的脉搏的设备、系统和方法

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010047140A1 (en) * 2000-02-04 2001-11-29 Freeman Gary A. Integrated resuscitation
US20040116969A1 (en) * 2002-08-26 2004-06-17 Owen James M. Pulse detection using patient physiological signals
US20130324855A1 (en) * 2012-05-31 2013-12-05 Nellcor Puritan Bennett Llc Methods and systems for power optimization in a medical device
US20140247274A1 (en) * 2013-03-04 2014-09-04 Nihon Kohden Corporation Display apparatus
JP2015143008A (ja) 2013-12-27 2015-08-06 Ｊｘ日鉱日石エネルギー株式会社 繊維強化複合材料製シャフト
JP2016096356A (ja) 2012-05-11 2016-05-26 株式会社半導体エネルギー研究所 半導体装置

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010047140A1 (en) * 2000-02-04 2001-11-29 Freeman Gary A. Integrated resuscitation
JP2012061361A (ja) 2000-02-04 2012-03-29 Zoll Medical Corp 救急蘇生用システム
US20040116969A1 (en) * 2002-08-26 2004-06-17 Owen James M. Pulse detection using patient physiological signals
JP2016096356A (ja) 2012-05-11 2016-05-26 株式会社半導体エネルギー研究所 半導体装置
US20130324855A1 (en) * 2012-05-31 2013-12-05 Nellcor Puritan Bennett Llc Methods and systems for power optimization in a medical device
US20140247274A1 (en) * 2013-03-04 2014-09-04 Nihon Kohden Corporation Display apparatus
JP2015143008A (ja) 2013-12-27 2015-08-06 Ｊｘ日鉱日石エネルギー株式会社 繊維強化複合材料製シャフト

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112469333A (zh) * 2018-07-26 2021-03-09 皇家飞利浦有限公司 用于检测对象的脉搏的设备、系统和方法

Similar Documents

Publication Publication Date Title
US10271748B2 (en) Patient monitor for determining microcirculation state
EP2931120B1 (fr) Système et procédé pour détecter des événements arythmiques importants à l'aide d'un photopléthysmographe (ppg) et d'un accéléromètre
JP7319995B2 (ja) 心肺蘇生中の自発循環再開の検出をサポートする装置、システム及び方法
WO2016031179A1 (fr) Dispositif de détection d'informations biologiques
JP2016510243A (ja) 被験者のバイタルサインを決定するシステム及び方法
US20150073239A1 (en) Continuous cuffless blood pressure measurement using a mobile device
JP5568037B2 (ja) 心肺蘇生術モニタリング装置
JP2018518303A (ja) 心肺蘇生法の最中における自発的な循環流動の復帰の決定
WO2009085818A3 (fr) Capteur optique et procédé de détection d'un état chez un patient
JP2020515300A (ja) ウェアラブルデバイスによりもたらされる紅斑の検出
US11510624B2 (en) Wireless vital sign monitoring
TW201716029A (zh) 具有心率分析模組之血壓計
WO2014107579A1 (fr) Système et méthode de détermination non invasive du débit cardiaque
WO2017013856A1 (fr) Appareil d'aide au sauvetage
JP2016187539A (ja) 生体情報測定システム
JP2013059439A (ja) 生体信号測定装置
US10966618B2 (en) Lifesaving assisting apparatus
US10561375B2 (en) Pulse photometer and method for evaluating reliability of calculated value of blood light absorber concentration
US11690576B2 (en) Apparatus and methods for detecting cardiac arrest
US9439576B2 (en) Lifesaving support apparatus and lifesaving support system
KR20170064906A (ko) 생체신호 측정장치 및 방법
JP7024261B2 (ja) 光学測定装置及び光学測定プログラム
US20230048928A1 (en) Pulse oximeter, pulse oximetry system, processing device, and pulse oximetry method
US20190246926A1 (en) Device for detecting atrial fibrillation of a subject
US20220192529A1 (en) Pulse recognition and blood oxygen saturation systems and methods

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 16745513

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 15745342

Country of ref document: US

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2016745513

Country of ref document: EP